Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page shows an updated revision: v3.4.3 replaces the previous v3.4.2. This is a backend/versioning update and does not alter clinical trial details presented.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.4.2 and the prior government-funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedA site-wide funding notice regarding government funding and operations was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check50 days agoChange DetectedAdded a 'Show glossary' option. Updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to 'Revision: v3.4.0' (from 'Revision: v3.3.4').SummaryDifference0.2%

- Check64 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no changes to study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a Texas listing under a new Locations section and removed the old 'Texas Locations' label to clarify site listings.SummaryDifference0.2%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.